ICICI Direct

• investments

Oberoi Realty is expected to register robust pre-sales over the next two years led by a sturdy launch pipeline. Buy for target price of ₹2200 (34% upside): ICICI Direct

Arjun October 21, 2026 0

The company saw lease rentals rising by ~16% YoY (up 2% QoQ) during Q2FY27...

Read More

• investments

Crompton Greaves Consumer Electricals is one of the leading fast moving electrical goods (FMEG) companies. Buy for target price of ₹275 (31% upside): ICICI Direct

Arjun October 19, 2026 0

The company has steadily improved revenue growth trajectory from single digit 3 quarters back...

Read More

• investments

BHEL has a strong order book and diversification will drive growth. Buy for target price of ₹605 (30% upside): ICICI Direct

Arjun October 16, 2026 0

BHEL is one of the largest engineering and manufacturing company of its kind in...

Read More

• investments

GEE is well positioned to deliver a strong earnings recovery supported by the expansion of installed capacity. Buy for target price of ₹170 (36% upside): ICICI Direct

Arjun October 15, 2026 0

GEE’s NPCIL approval strengthens its access to the highly regulated nuclear power segment

Read More

• investments

Gland Pharma is one of the largest generic injectable-focused B2B / CDMO company, with a global footprint. Buy for target price of ₹3430: ICICI Direct

Arjun October 7, 2026 0

Gland continues to grow in stature with its 100% injectables offerings across the globe...

Read More

• investments

Top Fundamental Picks for October 2026 by ICICI Direct

Arjun October 4, 2026 0

Rationale for Top Large Cap Picks Rationale for Top Mid and Small Cap Picks...

Read More

• investments

Symbiotec Pharmalab is moving into high-value extensions. Buy for target price of ₹1540 (28% upside): ICICI Direct

Arjun October 1, 2026 0

We believe the company has the required wherewithal to transition from a legacy API...

Read More

• investments

Tenneco Clean Air India is driving growth through regulation and premiumisation. Target price is ₹650 (30% upside): ICICI Direct

Arjun September 30, 2026 0

Tenneco is already a major supplier of shock absorbers and struts to Indian PV...

Read More

• investments

Indegene is addressing a US$135bn+ life-sciences operations market. Target price is ₹750: ICICI Direct

Arjun September 28, 2026 0

Indegene’s competitive positioning is supported by 27+ years of exclusive life - sciences experience

Read More

• investments

Pearl Global Industries targets revenues of Rs90 – 100bn by FY30. Buy for target price of ₹1600 (22% upside): ICICI Direct

Arjun September 25, 2026 0

PGIL’s EBIDTA margin expanded by 110bps to 9.2% over FY23-26 despite various uncertainties.

Read More